Who are Antibiotic and antifungal drugs's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): clindamycin phosphate/butoconazole nitrate, POLYGYNAX®.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/antibiotic-and-antifungal-drugs.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Antibiotic and antifungal drugs — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antibiotic and antifungal drugs (Antibiotic and antifungal drugs) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibiotic and antifungal. Area: Infectious Diseases.

phase 2 Antibiotic and antifungal Bacterial cell wall synthesis and fungal cell membrane function Infectious Diseases Small molecule Live · refreshed every 30 min

Target snapshot

Antibiotic and antifungal drugs (Antibiotic and antifungal drugs) — Gruppo Italiano Malattie EMatologiche dell'Adulto. Antibiotic and antifungal drugs work by inhibiting bacterial cell wall synthesis and interfering with fungal cell membrane function.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Antibiotic and antifungal drugs TARGET	Antibiotic and antifungal drugs	Gruppo Italiano Malattie EMatologiche dell'Adulto	phase 2	Antibiotic and antifungal	Bacterial cell wall synthesis and fungal cell membrane function
clindamycin phosphate/butoconazole nitrate	clindamycin phosphate/butoconazole nitrate	Lumara Health, Inc.	phase 3	Antibiotic and antifungal combination
POLYGYNAX®	POLYGYNAX®	Laboratoire Innotech International	phase 3	Combination antibiotic and antifungal agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibiotic and antifungal class)

Gruppo Italiano Malattie EMatologiche dell'Adulto · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Antibiotic and antifungal drugs — Competitive Intelligence Brief. https://druglandscape.com/ci/antibiotic-and-antifungal-drugs. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab